×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| ANUH PHARMA LTD. | 1898.68 | 83.01 | 1864.79 | 1.66 | 862.0 | 18.7 |
| IND-SWIFT LABORATORIES LTD. | 1673.16 | 87.75 | 1527.34 | 1.17 | 783 | 35.5 |
| Shree Ganesh Remedies Limited | NA | NA | NA | NA | 754 | 34.5 |
Anuh Pharma Ltd.,, with Security Code 506260, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 157.3 | 161.5 | 149.5 | 172.1 | 163.9 | 137.9 | 166.0 | 159.5 | 198.1 | 186.5 |
| Expenses | 143.1 | 147.5 | 131.6 | 148.1 | 144.7 | 127.3 | 149.1 | 144.7 | 179.4 | 176.2 |
| Operating Profit | 14.2 | 14.0 | 18.0 | 24.0 | 19.2 | 10.6 | 16.9 | 14.8 | 18.7 | 10.3 |
| OPM % | 9.05% | 8.65% | 12.01% | 13.94% | 11.73% | 7.66% | 10.17% | 9.27% | 9.45% | 5.52% |
| Other Income | 1.0 | 3.5 | 2.1 | 3.7 | 2.8 | 3.7 | 3.4 | 0.9 | 1.4 | 3.4 |
| Interest | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.3 | 0.0 | 0.2 |
| Depreciation | 2.4 | 2.0 | 2.1 | 2.2 | 2.2 | 1.9 | 1.9 | 2.2 | 2.8 | 2.5 |
| Profit before tax | 12.8 | 15.4 | 17.9 | 25.3 | 19.7 | 12.3 | 18.2 | 13.3 | 17.3 | 11.0 |
| Tax % | -25.1% | -23.8% | -22.6% | -24.5% | -22.1% | -22.5% | -17.3% | 22% | -27.8% | 24.2% |
| Net Profit | 9.6 | 11.8 | 13.8 | 19.1 | 15.4 | 9.5 | 15.0 | 10.3 | 12.5 | 8.3 |
| EPS in Rs | 0.96 | 1.18 | 1.38 | 1.91 | 1.53 | 0.95 | 1.5 | 1.03 | 0 | 1.66 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 15% |
| 3 Years: | 14% |
| TTM: | -2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 19% |
| 3 Years: | 32% |
| TTM: | -7% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 22% |
| 3 Years: | 30% |
| 1 Year: | -8% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|